Clin2
NCT06785272Possibly a fitRecruiting

Magnesium for children with asthma in the ER

Asthma

Treatments studied

Part of Immune system & allergy, Lungs & breathing clinical trials.

This trial tests if giving magnesium sulfate through an IV helps children with moderate to severe asthma attacks in the emergency department. If your child is between 2 and 17 years old and still has trouble breathing after three puffs of standard asthma medicine, this study may be an option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
192 people
Ages
2 years to 17 years
Study type
Interventional

Who can take part

  • Your child must be between 2 and 17 years old.
  • Your child must have been diagnosed with asthma or probable asthma by a doctor.
  • Your child must still have moderate to severe asthma symptoms after three treatments of inhaled asthma medicine in the ER.
  • Your child must not have received IV magnesium in the past 24 hours.
  • Your child must not need immediate breathing support like a breathing tube or special oxygen mask.
  • Your child must not have certain other serious health conditions (like kidney, heart, or lung disease).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06137040Recruiting· Early Phase 1
Early IV Magnesium for Moderate Asthma in Children

This trial tests whether giving magnesium sulfate through an IV early in the emergency room helps children aged 5–17 who are having a moderate asthma attack. It aims to improve breathing and reduce the need for hospital stays.

Oklahoma City, Oklahoma
NCT07795970Not yet recruiting
High-dose magnesium infusion for severe asthma in the emergency room

This trial tests whether giving a higher dose of magnesium (given as an IV drip) works better than the standard dose for treating a severe asthma attack in the emergency room. It aims to see if the higher dose helps you breathe easier sooner.

NCT06955559Not yet recruiting· Phase 3
Magnesium sulfate for childhood asthma and bronchiolitis

This study tests if giving magnesium sulfate (a mineral supplement) helps children with asthma or bronchiolitis breathe better. It is for children aged 1 month to under 18 years who have these conditions.

NCT07173855Recruiting· Phase 4
Magnesium replacement in ICU patients

This trial tests whether giving magnesium as part of a standard hospital protocol can lower the risk of irregular heartbeat and improve survival in patients admitted to the intensive care unit.

Ajax, Ontario
NCT07655817Recruiting· Phase 2/Phase 3
Magnesium for reducing confusion after surgery in children

This trial tests if giving magnesium through the mouth works as well as through the vein to prevent confusion or agitation right after surgery in children having their tonsils out. It aims to find a simpler way to help kids wake up calmly.

Tanta, Gharbia Governorate
NCT05736744Recruiting· Phase 2/Phase 3
Magnesium before surgery in children to reduce complications

This study tests whether giving magnesium before planned (elective) keyhole abdominal surgery can improve outcomes in children. It may help reduce problems related to anesthesia and muscle function during and after surgery.

Asyut, Assiut Governorate

Hear when a new Asthma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.